Tag: investing
-
![Perimeter Medical Imaging AI (PINK.V) technology advances as ACS reports 2.3 million new breast cancer cases]()
Perimeter Medical Imaging AI (PINK.V) technology advances as ACS reports 2.3 million new breast cancer cases
In 25% of Breast Lumpectomy surgeries, cancerous material is left behind. With current technology, the surgeon needs to wait about a week, to see if he’s got all the cancerous material.
-
Medexus Pharmaceuticals (MDP.V), poised for flight on the Nasdaq (coming soon)
If you are like me and health sciences is your sector of choice when it comes to investing in the markets, you’d better be very patient, love doing research – and a willingness to see it through!!! A sector famous for its high-risk-high-reward characteristics is definitely not recommended for the faint of heart. Lucky for…
-
Perimeter Medical Imaging AI (PINK.V): the power of a simple story
No need to cut the patient open again later. The surgeon can make adjustments on the fly.
-
Perimeter Medical Imaging AI (PINK.V) shuffles the deck
PINK is accelerating toward the commercialisation of the OTIS platform. It has already received a $7.4 million grant (non-dilutive capital) from the Cancer Prevention and Research Institute of Texas (CPRIT) to fund the ATLAS AI Project.
-
Perimeter Medical Imaging AI (PINK.V) untapped value in medtech
Investing your money in health or medical companies is difficult. The complexity of the science often deters investors from allocating a portion of their portfolio to said industry, despite those companies having proven potential to provide the largest gains for its investors. We’re not criticizing – everyone knows that medical terminology is only second to…
-
Biotech: Who will survive when the Covid-19 Hype Ends? Part II
For part I of this series please click here. Cities across Canada are gradually returning to business as usual, and we’re winning the fight against Covid-19 (don’t look south of the border). Thanks to all citizens still wearing hats to hide their botched home-haircuts, and our essential workers who literally put their lives on the…
-
Biotech: Who Will Survive When The COVID-19 Hype Ends?
Over the last couple of months, companies have found a way to muster up an effort to align their objectives with helping society recover from this global pandemic – COVID-19. The result: share prices have soared like never before. The line up of biotech companies trying to come up with COVID-19 vaccines or cures is…
-
![Millennial Lithium (ML.V), full speed ahead… initial production in 2022]()
Millennial Lithium (ML.V), full speed ahead… initial production in 2022
Earlier this month, the Mining Court of Salta granted Millennial Lithium’s (TSX-V: ML) / (OTCQX: MLNLF) Argentine subsidiary four mining licenses on its 100%-owned Pastos Grandes project in Salta province. Readers may recall that Millennial recently delivered a Bank Feasibility Study (“BFS“) and expects to reach initial production in 2022 (subject to funding & permits),…
-
![Bitcoin trader makes dumb greedy bet – loses $16 million – kills himself, triggering painful shotgun-in-mouth memory of even dumber, greedier Amazon (AMZN.Q) bet]()
Bitcoin trader makes dumb greedy bet – loses $16 million – kills himself, triggering painful shotgun-in-mouth memory of even dumber, greedier Amazon (AMZN.Q) bet
A few weeks ago, a Chinese Bitcoin trader, Hui Yi, embezzled 2,000 Bitcoins, used them as collateral to take a highly leveraged (100x) short position on the price of Bitcoin. The co-founder and CEO of a crypto market analysis platform, Hui got the timing and direction of his bet horrendously wrong. WeChat messages indicate that…
-
![Long and Short (Ep 2): The rate cut and what it means]()
Long and Short (Ep 2): The rate cut and what it means
For the first time since 2008, the Fed cut rates by 25 basis points to boost economic growth. In a perfect world, a lower cost of borrowing would’ve made the market soar. But stocks fell yesterday, and they fell today. It’s complicated. Let’s get into it: Interest rates and the economy The interest rates set…
